Overview

Megadose of Hydroxocobalamin for the Treatment of Pernicious Anemia

Status:
Completed
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
Demonstrate the effectiveness of a single dose of a multivitamin complex for the treatment of megaloblastic anemia
Phase:
Phase 4
Details
Lead Sponsor:
Hospital Universitario Dr. Jose E. Gonzalez
Treatments:
Hydroxocobalamin
Pyridoxine
Thiamine
Vitamin B 12